Article
CADTH Update Outlines Revisions To Biosimilar And Pharmaceutical Review Programs
In its Common Drug Review (CDR) Update – Issue 133 (with further details in Revisions to CADTH's Biosimilar and Resubmission Processes, Other Administrative Changes...

Smart & Biggar





